Epidemiological features of lung giant cell carcinoma and therapy for patients with EGFR mutations based on case reports and the surveillance, epidemiology, and end results (SEER) database

Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) are the standard first line treatment for advanced non-small cell lung cancer (NSCLC) with sensitive EGFR mutations. Among NSCLC, giant cell carcinoma of the lung (GCCL) is a rare pathological subtype with poor prognosis, with n...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Shan-Shan, Cao, Ying, Tang, Xiu-Jun, Zhu, Li-Zhen, Tan, Yi-Nuo, Dong, Cai-Xia, Chen, Jia-Qi, Shen, Hong, Yuan, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421933/
https://www.ncbi.nlm.nih.gov/pubmed/28445978
http://dx.doi.org/10.18632/oncotarget.15831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421933/
https://www.ncbi.nlm.nih.gov/pubmed/28445978
http://dx.doi.org/10.18632/oncotarget.15831

Ejemplares similares